semaglutide and colitis Patients with stable inflammatory bowel disease (IBD) comorbid obesity and/or diabetes who started GLP-1 receptor agonists (semaglutide or tirzepatide) alongside ongoing treatment did not have a lower risk for the relapse Semaglutide and Crohn's Disease: Safety,

On the contrary, insulin therapy has been associated with weight gain and increased risk of cardiovascular events [112, 113], which are common risk factors in patients diagnosed with NAFLD

is the worldwide leader in per capita prescription drug spending, representing between 30% and 40% of the global market

cities and digital channels in the coming months

By delivering a concentrated dose directly into your bloodstream, these injections can rapidly elevate your Vitamin D status, leading to increased energy, improved mood, and a stronger immune system

These medications have received regulatory approval worldwide and are fairly safe, with a low incidence of side effects